Are tumors too diverse for non-individualized cancer vaccines?
Because of the immense genetic diversity of tumors, developing cancer vaccines is a daunting prospect. To investigate the feasibility of non-individualized… Read more »
Ryan Hartmaier is a senior scientist in the Cancer Genomics group at Foundation Medicine. His background is in NGS bioinformatics and cancer molecular biology. Currently, he leads efforts to leverage molecular information from large genomic datasets to inform our understanding of cancer biology, guide drug discovery efforts, and help bridge genomics into individualized medicine.
Latest posts by Ryan Hartmaier (see all)
- Are tumors too diverse for non-individualized cancer vaccines? - 24th February 2017